SI-BONE Reaffirms 2026 Revenue Outlook Amid Accelerating Procedure Demand and Onyx Launch
SI-BONE (SIBN) reported a solid third quarter characterized by accelerating procedure demand, broader physician adoption, and improving financial performance. CEO Laura Francis emphasized the company's disciplined execution of its multiyear strategy to expand its differentiated platform into new clinical applications. A key driver for future growth is the upcoming launch of Onyx, which targets an estimated $5 billion annual market opportunity. The company has reaffirmed its revenue outlook for 2026, signaling confidence in its long-term commercial trajectory and market expansion capabilities.
Tickers: $SIBN
Topics: earnings report financial performance procedure demand strategic expansion
Read the full article at Seeking Alpha
Part of the story Airbus Reports €50.65B Revenue and Reaffirms FY 2026 Outlook (3 articles)